Catalyst Wire Dossier Catalyst Wire Dossier

OXD01

· Orexo AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OXD01, covering 2025-06-27 to 2025-06-27. Get the full timeline:

Most recent: Clinical Trial Update: OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder [NA]

See pricing